Success Metrics

Clinical Success Rate
88.5%

Based on 23 completed trials

Completion Rate
88%(23/26)
Active Trials
0(0%)
Results Posted
43%(10 trials)
Terminated
3(12%)

Phase Distribution

Ph not_applicable
5
19%
Ph phase_2
6
23%
Ph phase_1
4
15%
Ph phase_3
6
23%
Ph phase_4
5
19%

Phase Distribution

4

Early Stage

6

Mid Stage

11

Late Stage

Phase Distribution26 total trials
Phase 1Safety & dosage
4(15.4%)
Phase 2Efficacy & side effects
6(23.1%)
Phase 3Large-scale testing
6(23.1%)
Phase 4Post-market surveillance
5(19.2%)
N/ANon-phased studies
5(19.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.5%

23 of 26 finished

Non-Completion Rate

11.5%

3 ended early

Currently Active

0

trials recruiting

Total Trials

26

all time

Status Distribution
Completed(23)
Terminated(3)

Detailed Status

Completed23
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
26
Active
0
Success Rate
88.5%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (15.4%)
Phase 26 (23.1%)
Phase 36 (23.1%)
Phase 45 (19.2%)
N/A5 (19.2%)

Trials by Status

terminated312%
completed2388%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT00880594Not Applicable

Irritable Bowel Syndrome (IBS) Functional Magnetic Resonance Imaging (fMRI) With Desipramine

Terminated
NCT03548454Phase 4

Comparing Effectiveness of Duloxetine and Desipramine in Patients With Chronic Pain: A Pragmatic Trial Using Point of Care Randomization

Completed
NCT00220844Not Applicable

Tricyclic Antidepressants (TCAs) on Gastric Emptying

Terminated
NCT03726996Phase 4

Desipramine in Infantile Neuroaxonal Dystrophy (INAD).

Terminated
NCT01265550Phase 3

A Randomized Trial of Medical and Surgical Treatments for Patients With GERD Symptoms That Are Refractory to Proton Pump Inhibitors

Completed
NCT00456014Not Applicable

Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant Treatment

Completed
NCT01358968Phase 1

A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine

Completed
NCT00000271Phase 2

New Approaches to Cocaine Abuse Medications (A) - 6

Completed
NCT02428478Phase 2

Effect of Desipramine on Genioglossus Muscle Activity in Healthy Adults Study A

Completed
NCT02436031Phase 2

Effect of Desipramine on Upper Airway Collapsibility and Genioglossus Muscle Activity in Patients With Obstructive Sleep Apnea - Study B

Completed
NCT00000245Phase 2

Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1

Completed
NCT00000321Phase 4

Methamphetamine Abuse Treatment in Patients With AIDS - 1

Completed
NCT00338962Phase 3

Naltrexone & SSRI in Alcoholics With Depression/PTSD

Completed
NCT00000376Not Applicable

Cognitive and Drug Therapy for Drug-Resistant Depression

Completed
NCT00000212Phase 2

IV Cocaine Abuse: A Laboratory Model - 1

Completed
NCT00320632Phase 4

Desipramine for Improving Cellular Signaling and Decreasing Symptoms of Major Depression

Completed
NCT00166114Phase 4

Depression, Epinephrine, and Platelet Function

Completed
NCT01478568Phase 1

To Evaluate the Effect of Mirabegron (YM178) on Blood Levels of Desipramine When They Are Taken Together

Completed
NCT00018200Phase 2

Effect of Antidepressants on Back Pain

Completed
NCT01415128Phase 1

Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male Subjects

Completed

Drug Details

Intervention Type
DRUG
Total Trials
26